Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

I Roots

Showing results (171-180 of 225) with videos related to

Pageof 23
Sort By:
Pharmacogenetics|September 7, 2000
Characterization of the glutathione S-transferase GSTT1 deletion: discrimination of all genotypes by polymerase chain reaction indicates a trimodular genotype-phenotype correlationR Sprenger, R Schlagenhaufer, R Kerb, et al.
Blood|October 21, 2000
The platelet glycoprotein Ia C807T polymorphism as risk factor for coronary catheter interventionsC Meisel, I Cascorbi, A Herrmann, et al.
European Journal of Clinical Investigation|March 19, 2003
Quantitative determination of MDR1 mRNA expression in peripheral blood lymphocytes: a possible role of genetic polymorphisms in the MDR1 geneK Oselin, I Nowakowski-Gashaw, P M Mrozikiewicz, et al.
Gynecologic Oncology|January 22, 2016
The influence of polypharmacy on grade III/IV toxicity, prior discontinuation of chemotherapy and overall survival in ovarian cancerH Woopen, R Richter, F Ismaeel, et al.
International Journal of Clinical Pharmacology and Therapeutics|December 10, 1999
Omeprazole weakly inhibits CYP1A2 activity in manK L Rost, U Fuhr, T Thomsen, et al.
Drug Metabolism Reviews|May 21, 1999
Induction of CYP1A by various benzimidazoles and its significance in administrative drug regulationU Kleeberg, R Frötschl, S Krusekopf, et al.
Molecular Psychiatry|March 24, 2004
Pharmacogenetics of antidepressants and antipsychotics: the contribution of allelic variations to the phenotype of drug responseJ Kirchheiner, K Nickchen, M Bauer, et al.
British Journal of Clinical Pharmacology|December 14, 1999
Population frequency, mutation linkage and analytical methodology for the Arg16Gly, Gln27Glu and Thr164Ile polymorphisms in the beta2-adrenergic receptor among TurksA S Aynacioglu, I Cascorbi, K Güngör, et al.
Toxicology and Applied Pharmacology|June 22, 1999
Paraoxonase 1 mutations in a Turkish populationA S Aynacioglu, I Cascorbi, P M Mrozikiewicz, et al.
Molecular Psychiatry|July 13, 2000
Dopamine D4 receptor 48-bp repeat polymorphism: no association with response to antipsychotic treatment, but association with catatonic schizophreniaR Kaiser, M Könneker, M Henneken, et al.
Pageof 23

Showing results (171-180 of 225) with videos related to

Sort By:
Pageof 23
Pharmacogenetics|September 7, 2000
Characterization of the glutathione S-transferase GSTT1 deletion: discrimination of all genotypes by polymerase chain reaction indicates a trimodular genotype-phenotype correlationR Sprenger, R Schlagenhaufer, R Kerb, et al.
Blood|October 21, 2000
The platelet glycoprotein Ia C807T polymorphism as risk factor for coronary catheter interventionsC Meisel, I Cascorbi, A Herrmann, et al.
European Journal of Clinical Investigation|March 19, 2003
Quantitative determination of MDR1 mRNA expression in peripheral blood lymphocytes: a possible role of genetic polymorphisms in the MDR1 geneK Oselin, I Nowakowski-Gashaw, P M Mrozikiewicz, et al.
Gynecologic Oncology|January 22, 2016
The influence of polypharmacy on grade III/IV toxicity, prior discontinuation of chemotherapy and overall survival in ovarian cancerH Woopen, R Richter, F Ismaeel, et al.
International Journal of Clinical Pharmacology and Therapeutics|December 10, 1999
Omeprazole weakly inhibits CYP1A2 activity in manK L Rost, U Fuhr, T Thomsen, et al.
Drug Metabolism Reviews|May 21, 1999
Induction of CYP1A by various benzimidazoles and its significance in administrative drug regulationU Kleeberg, R Frötschl, S Krusekopf, et al.
Molecular Psychiatry|March 24, 2004
Pharmacogenetics of antidepressants and antipsychotics: the contribution of allelic variations to the phenotype of drug responseJ Kirchheiner, K Nickchen, M Bauer, et al.
British Journal of Clinical Pharmacology|December 14, 1999
Population frequency, mutation linkage and analytical methodology for the Arg16Gly, Gln27Glu and Thr164Ile polymorphisms in the beta2-adrenergic receptor among TurksA S Aynacioglu, I Cascorbi, K Güngör, et al.
Toxicology and Applied Pharmacology|June 22, 1999
Paraoxonase 1 mutations in a Turkish populationA S Aynacioglu, I Cascorbi, P M Mrozikiewicz, et al.
Molecular Psychiatry|July 13, 2000
Dopamine D4 receptor 48-bp repeat polymorphism: no association with response to antipsychotic treatment, but association with catatonic schizophreniaR Kaiser, M Könneker, M Henneken, et al.
Pageof 23